Cargando…
Molecular MRI of Atherosclerosis
Despite advances in prevention, risk assessment and treatment, coronary artery disease (CAD) remains the leading cause of morbidity and mortality in Western countries. The lion’s share is due to acute coronary syndromes (ACS), which are predominantly triggered by plaque rupture or erosion and subseq...
Autores principales: | Phinikaridou, Alkystis, Andia, Marcelo E., Lacerda, Sara, Lorrio, Silvia, Makowski, Marcus R., Botnar, René M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270261/ https://www.ncbi.nlm.nih.gov/pubmed/24232739 http://dx.doi.org/10.3390/molecules181114042 |
Ejemplares similares
-
Development of a tropoelastin-binding MR contrast agent for in vivo imaging of impaired elastogenesis in atherosclerosis
por: Phinikaridou, Alkystis, et al.
Publicado: (2015) -
Sustained Focal Vascular Inflammation Accelerates Atherosclerosis in Remote Arteries
por: Lavin Plaza, Begoña, et al.
Publicado: (2020) -
Noninvasive MRI Monitoring of the Effect of Interventions on Endothelial Permeability in Murine Atherosclerosis Using an Albumin‐Binding Contrast Agent
por: Phinikaridou, Alkystis, et al.
Publicado: (2013) -
Tropoelastin: an in vivo imaging marker of dysfunctional matrix turnover during abdominal aortic dilation
por: Lavin, Begoña, et al.
Publicado: (2019) -
Multi-sequence non-contrast MRI characterization of deep vein thrombosis in man
por: Phinikaridou, Alkystis, et al.
Publicado: (2015)